Опухоли головы и шеи. 2013; : 10-20
ОБЩИЕ АСПЕКТЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯ МЕСТНО-РАСПРОСТРАНЕННОГО РАКА ЩИТОВИДНОЙ ЖЕЛЕЗЫ
https://doi.org/10.17650/2222-1468-2013-0-2-10-20Аннотация
Статья посвящена анализу современных тенденций в диагностике и лечении местно-распространенного, рецидивного и мета- статического медуллярного и высокодифференцированного рака щитовидной железы (ЩЖ). Освещены вопросы диагностики и хирургического лечения данной патологии на основе опыта нашей клиники. Приведены данные о мировых тенденциях консервативного лечения высокодифференцированных рефрактерных к радиойодтерапии опухолей ЩЖ, а также распространенного и метастатического медуллярного рака.
Список литературы
1. Avenia N., Monacelli M., Sanguenetti A. et al. Therapeutic options in locally advanced thyroid carcinoma. Our experience. Аnn Ital Chir 2012;Nov–Dec;83(6):481–5.
2. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract 2001;7(3):175–7.
3. Чиссов В.И., Старинский В.В. Состояние онкологической помощи населению в России в 1999 году. М.: Ранко-пресс, 2000. 176 с.
4. Валдина Е.А. Заболевания щитовидной железы. М.: Медицина, 1993. С. 53–58.
5. Пачес А.И., Пропп Р.М. Рак щитовидной железы. М.: Медицина, 1995. С. 83–85.
6. Shaha A.R., Shah J.P. Recurrent Differentiated Thyroid Cancer. Endocrin Pract 2012 Jul;11:1–11.
7. Ontal K.I., Straehley C.J. The surgical treatment of well-differentiated carcinoma of the thyroid. Amer Surg 1985;3(11):146–51.
8. Vickery L. Jr, Wang C.A., Walker A.M. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 1987; 60(11):2587–95.
9. Черников Р.А., Бабунов А.Ф., Фельдшеров И.М. Отдаленные результаты лечения папиллярного рака щитовидной железы. Материалы III тиреоидологического конгресса. М., 2004. С. 312.
10. Ishichara T., Kukichi K., Ikeda T. Resection of thyroid carcinoma with infiltration of the trachea. Thorax 1978;33:204–10.
11. Hopkins C.R., Reading C.C. Thyroid and parathyroid imaging. Semin Ultrasound CT MR 1995;16(4);279–95.
12. de Meer S.G., Schreinemakers J.M., Zelissen P.M. et al. Fine-needle aspiration of thyroid tumors: identifying factors associated with adequacy rate in a large academic center in the Netherlands. Diagn Cytopathol 2012 May;40 Suppl 1:E21–6.
13. Серебров В.Т. Топографическая анатомия. Томск, 1961. С. 121.
14. Lee Yoon Se et al. Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Ann Surg Oncol 2011;18(12):3486–92. 15. Leboulleux S., Bastholt L., Krause T. et al. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomized, double-blind, phase 2 trial. Lancet Oncol 2012 Sep;13(9):897–905.
15. Frampton J.E. Vandetanib: in medullary thyroid cancer. Drugs 2012 Jul 9;72(10):1423–36. 17. Degrauwe N., Sosa J.A., Roman S., Deshpande H.A. Vandetanib for the treatment of metastatic medullary thyroid cancer. Clin Med Insights Oncol 2012;6:243–52.
16. Smit J. Treatment of advanced medullary thyroid cancer. Thyroid Res 2013 Mar 14;6 Suppl 1:S7.
17. Grabowski P., Briest F., Baum R.P. et al. Vandetanib therapy in medullary thyroid cancer. Drugs Today (Barc) 2012 Nov; 48(11):723–33.
18. Wu X., Jin Y., Cui I.H. et al. Addition of vandetanib to chemotherapy in advanced solid cancers: a meta-analysis. Anticancer Drugs 2012 Aug;23(7):731–8.
Head and Neck Tumors (HNT). 2013; : 10-20
GENERAL ASPECTS OF THE DIAGNOSIS AND TREATMENT OF LOCALLY ADVANCED THYROID CANCER
https://doi.org/10.17650/2222-1468-2013-0-2-10-20Abstract
The paper deals with current trends in the diagnosis and treatment of locally advanced, recurrent and metastatic medullary and low-grade thyroid cancer. It highlights problems in the diagnosis and surgical treatment of this pathology on the basis of our clinic’s experience. Data on global trends in medical treatment for low-grade radioactive iodine therapy-refractory thyroid tumors, as well as disseminated and metastatic medullary cancer are given.
References
1. Avenia N., Monacelli M., Sanguenetti A. et al. Therapeutic options in locally advanced thyroid carcinoma. Our experience. Ann Ital Chir 2012;Nov–Dec;83(6):481–5.
2. AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. Endocr Pract 2001;7(3):175–7.
3. Chissov V.I., Starinskii V.V. Sostoyanie onkologicheskoi pomoshchi naseleniyu v Rossii v 1999 godu. M.: Ranko-press, 2000. 176 s.
4. Valdina E.A. Zabolevaniya shchitovidnoi zhelezy. M.: Meditsina, 1993. S. 53–58.
5. Paches A.I., Propp R.M. Rak shchitovidnoi zhelezy. M.: Meditsina, 1995. S. 83–85.
6. Shaha A.R., Shah J.P. Recurrent Differentiated Thyroid Cancer. Endocrin Pract 2012 Jul;11:1–11.
7. Ontal K.I., Straehley C.J. The surgical treatment of well-differentiated carcinoma of the thyroid. Amer Surg 1985;3(11):146–51.
8. Vickery L. Jr, Wang C.A., Walker A.M. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 1987; 60(11):2587–95.
9. Chernikov R.A., Babunov A.F., Fel'dsherov I.M. Otdalennye rezul'taty lecheniya papillyarnogo raka shchitovidnoi zhelezy. Materialy III tireoidologicheskogo kongressa. M., 2004. S. 312.
10. Ishichara T., Kukichi K., Ikeda T. Resection of thyroid carcinoma with infiltration of the trachea. Thorax 1978;33:204–10.
11. Hopkins C.R., Reading C.C. Thyroid and parathyroid imaging. Semin Ultrasound CT MR 1995;16(4);279–95.
12. de Meer S.G., Schreinemakers J.M., Zelissen P.M. et al. Fine-needle aspiration of thyroid tumors: identifying factors associated with adequacy rate in a large academic center in the Netherlands. Diagn Cytopathol 2012 May;40 Suppl 1:E21–6.
13. Serebrov V.T. Topograficheskaya anatomiya. Tomsk, 1961. S. 121.
14. Lee Yoon Se et al. Clinical implications of bilateral lateral cervical lymph node metastasis in papillary thyroid cancer: a risk factor for lung metastasis. Ann Surg Oncol 2011;18(12):3486–92. 15. Leboulleux S., Bastholt L., Krause T. et al. Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomized, double-blind, phase 2 trial. Lancet Oncol 2012 Sep;13(9):897–905.
15. Frampton J.E. Vandetanib: in medullary thyroid cancer. Drugs 2012 Jul 9;72(10):1423–36. 17. Degrauwe N., Sosa J.A., Roman S., Deshpande H.A. Vandetanib for the treatment of metastatic medullary thyroid cancer. Clin Med Insights Oncol 2012;6:243–52.
16. Smit J. Treatment of advanced medullary thyroid cancer. Thyroid Res 2013 Mar 14;6 Suppl 1:S7.
17. Grabowski P., Briest F., Baum R.P. et al. Vandetanib therapy in medullary thyroid cancer. Drugs Today (Barc) 2012 Nov; 48(11):723–33.
18. Wu X., Jin Y., Cui I.H. et al. Addition of vandetanib to chemotherapy in advanced solid cancers: a meta-analysis. Anticancer Drugs 2012 Aug;23(7):731–8.
